This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Is Monsanto Too Controversial to Buy?

ST. LOUIS ( TheStreet) -- Depending on who you talk to, the name Monsanto (MON - Get Report) brings to mind vastly different notions.

To the investor, it means a way to play the fluctuations in the agriculture business. Or it refers to an innovative high-tech company whose shares offer a long-term bet based on a certain Malthusian logic: the more people there are on earth, the more we'll need the world's harvests to yield lots of food -- or else.

To many competitors and farmers -- and, quite likely, the federal government -- Monsanto brings to mind the hard-line tactics of a monopolist, a company that allegedly strong-arms customers into using its seed traits, and forces rivals into licensing agreements that prevent their twining of genes onto those branded by Monsanto. At least that's the contention of DuPont (DD - Get Report), among others, which has filed a civil lawsuit against the St. Louis agricultural company, alleging antitrust violations.

Monsanto, of course, disputes these characterizations: Its domination of the seed industry, it says, has occurred because of its huge investment in developing genetically engineered crop technologies, and the superior seeds that have resulted.

And to environmentalists and consumer advocates, Monsanto is a corporate goliath that has succeeded in bringing dangerous technologies into widespread use by farmers around the world. Dangerous, they say, because of the hegemony one company appears to have won over the food supply. And dangerous, others claim, because genetically engineered, mono-culture crops could both destabilize ecologies and, ironically enough, wind up harming agricultural productivity.

(One recent worry involves an Alfalfa seed developed by Monsanto, which some say could contaminate nearby crops. A legal injunction has blocked the company from selling the seeds, pending the completion of an environmental impact study. The case is now on the docket of the U.S. Supreme Court.)
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DD $64.26 0.00%
MON $91.65 0.00%
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs